The Lancet Gastroenterology & Hepatology in conversation with
Celková doba trvání:
11 h 21 min
Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
The Lancet Gastroenterology & Hepatology in conversation with
26:52
Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
The Lancet Gastroenterology & Hepatology in conversation with
19:05
John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer
The Lancet Gastroenterology & Hepatology in conversation with
13:29
Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
The Lancet Gastroenterology & Hepatology in conversation with
21:23
Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures
The Lancet Gastroenterology & Hepatology in conversation with
11:15
Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis
The Lancet Gastroenterology & Hepatology in conversation with
14:42
Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease
The Lancet Gastroenterology & Hepatology in conversation with
34:15
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer
The Lancet Gastroenterology & Hepatology in conversation with
18:23
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
The Lancet Gastroenterology & Hepatology in conversation with
25:05
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
The Lancet Gastroenterology & Hepatology in conversation with
23:16
Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease
The Lancet Gastroenterology & Hepatology in conversation with
19:55
Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa
The Lancet Gastroenterology & Hepatology in conversation with
20:54
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
The Lancet Gastroenterology & Hepatology in conversation with
16:39
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity
The Lancet Gastroenterology & Hepatology in conversation with
23:19
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
The Lancet Gastroenterology & Hepatology in conversation with
14:40
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
The Lancet Gastroenterology & Hepatology in conversation with
14:45
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease
The Lancet Gastroenterology & Hepatology in conversation with
16:19
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction
The Lancet Gastroenterology & Hepatology in conversation with
16:31
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
The Lancet Gastroenterology & Hepatology in conversation with
14:29
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
The Lancet Gastroenterology & Hepatology in conversation with
17:41
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
The Lancet Gastroenterology & Hepatology in conversation with
12:48
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
The Lancet Gastroenterology & Hepatology in conversation with
17:15
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
The Lancet Gastroenterology & Hepatology in conversation with
20:00
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
The Lancet Gastroenterology & Hepatology in conversation with
21:30
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
The Lancet Gastroenterology & Hepatology in conversation with
20:20
Dan Turner on vedolizumab in children with IBD
The Lancet Gastroenterology & Hepatology in conversation with
14:51
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
The Lancet Gastroenterology & Hepatology in conversation with
15:21
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
The Lancet Gastroenterology & Hepatology in conversation with
13:48
Filip Knop on liraglutide for bile acid diarrhoea
The Lancet Gastroenterology & Hepatology in conversation with
15:02
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
The Lancet Gastroenterology & Hepatology in conversation with
14:06
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
The Lancet Gastroenterology & Hepatology in conversation with
10:26
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
The Lancet Gastroenterology & Hepatology in conversation with
09:50
Juan Pablo Arab on NAFLD public health policies in the Americas
The Lancet Gastroenterology & Hepatology in conversation with
17:06
Sarah Blach on hepatitis C virus epidemiology
The Lancet Gastroenterology & Hepatology in conversation with
08:57
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection
The Lancet Gastroenterology & Hepatology in conversation with
15:02
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
The Lancet Gastroenterology & Hepatology in conversation with
13:43
Swati Patel on early-onset colorectal cancer
The Lancet Gastroenterology & Hepatology in conversation with
19:27
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands
The Lancet Gastroenterology & Hepatology in conversation with
09:39
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa
The Lancet Gastroenterology & Hepatology in conversation with
22:34
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
The Lancet Gastroenterology & Hepatology in conversation with
07:02
